GlassScriptPhysician profile
Adeeb Jay Dwairy
NPI 1679826929
$5,029.83
in general payments reported to CMS, 2019-2025
40 companies · $1,862 in 2025
The $1,862 reported for 2025 was more than what 77% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $406 · 2021: $453 · 2022: $659 · 2023: $332 · 2024: $894 · 2025: $1,862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,088.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,097.96 | 2019-2025 | Mavyret, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $424.47 | 2019-2025 | Xifaxan |
| Madrigal Pharmaceuticals | $407.64 | 2025 | Rezdiffra |
| Braintree Laboratories, INC. | $349.52 | 2019-2023 | Sutab |
| Janssen Biotech, INC. | $256.65 | 2025 | Tremfya |
| Gilead Sciences, INC. | $183.85 | 2019-2025 | |
| Axonics, INC. | $162.67 | 2024 | Axonics |
| Lilly USA, LLC | $153.35 | 2025 | Omvoh |
| Ironwood Pharmaceuticals, INC | $150.86 | 2019-2022 | |
| Evoke Pharma, INC. | $138.21 | 2023-2025 | Gimoti |
| Anx Robotica Corp | $126.83 | 2024 | |
| Janssen Scientific Affairs, LLC | $125.85 | 2025 | Stelara, Tremfya |
| E.R. Squibb & Sons, L.L.C. | $124.40 | 2024 | Zeposia |
| Boston Scientific Corporation | $120.04 | 2022 | |
| Redhill Biopharma INC. | $108.06 | 2020-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeeb Dwairy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.